Coffee Consumption Reduces Fibrosis Risk in those with Fatty Liver Disease

Visitors:117
Today\\\'s Visitors: 0
Total Visitors This week: 1071359

Increased coffee intake significantly decreases risk in nonalcoholic steatohepatitis patients Continue reading

Milk Thistle Provides a Protective Shield to the Liver, Heart and Brain

Visitors:183
Today\\\'s Visitors: 0
Total Visitors This week: 1071359

The liver is one of the most critical organs essential to human health. It serves more than 300 functions in the body to detoxify against chemical and environmental intrusions, and it promotes metabolic function as well. Silymarin is commonly known as milk thistle, and new science is emerging to validate the healing potential of this powerful plant. Publishing in the journal Hepatitis Monthly, researchers provide solid evidence that natural milk thistle extracts can halt and even reverse the effects of nonalcoholic fatty liver disease (NAFLD), an affliction affecting as much as a third of the adult population. Supplementation with milk thistle will dramatically lower the risks associated with fatty liver disease, atherosclerosis and cognitive dysfunction.

NAFLD is a significant health concern that is growing at an unprecedented rate due to the obesity and diabetes epidemic currently gripping most western societies. The condition is caused in part by excess accumulation of fats (triglycerides) in the cellular matrix of the liver that results in suboptimal function of the organ. Left unchecked, the disease can result in cell injury and damage, in inflammation and ultimately in cirrhosis as the liver becomes less able to perform the multitude of tasks essential to life. Continue reading

New Gene Sites Affecting Non Alcoholic Fatty Liver Disease Discovered

Visitors:158
Today\\\'s Visitors: 0
Total Visitors This week: 1071359

NAFLD is a condition where fat accumulates in the liver (steatosis) and can lead to liver inflammation (nonalcoholic steatohepatitis or NASH) and permanent liver damage (fibrosis/cirrhosis). NAFLD affects anywhere from 11% to 45% of some populations and is associated with obesity, hypertension, and problems regulating serum lipids or glucose.

“These findings will help us to better diagnose, manage, and treat NAFLD in the future and help explain why some but not all people with obesity develop particular complications of obesity; some carry genetic variants that predispose them to some but not other metabolic diseases.” says lead author Elizabeth K. Speliotes, M.D., Ph.D., M.P.H., an Assistant Professor of Gastroenterology, Internal Medicine, and Computational Medicine Continue reading